Zurück zu Projekte

25776.1 PFLS-LS

Identification of tumor antigens in cancer patients by a novel technology

Zusammenfassung

Identification of tumor antigens in cancer patients by a novel technology

Weitere Texte

Abstract

Vaccination against cancer is a promising therapeutic approach. Unfortunately, tumor antigens recognized by the immune system remain largely unknown. We have established a novel technology that allows fast and effective identification of such antigens recognized by tumor infiltrating T cells of individual patients. This knowledge provides the basis for development of efficient personalized cancer vaccines. We have verified our technology in various mouse models. With this project we will make the first step towards taking in to the clinics.

Beteiligte

Manfred Kopf

Kontaktperson

manfred.kopf@biol.ethz.ch

ETH Zürich Manfred Kopf Otto-Stern-weg 7 8093 Zürich ZH CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2017-03-31
Enddatum
2018-09-30
Bewilligte Gesamtkosten
CHF 395658.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%